Evidence map›Paper›PMID 29445365›Full record

ArticleFrontiers in microbiology2018

Vitomir Djokic, Lavoisier Akoolo, Nikhat Parveen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 49 citations in OpenAlex.

  1. Acquired motility ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Immunity beyond borders: non-lethalFrontiers in immunology · 2026
    Article
  3. A Set of Rapid Diagnostic Tool for Babesia microti Infection.Journal of clinical laboratory analysis · 2025
    Article
  4. Long-term survival ofMicrobiology spectrum · 2025
    Article
  5. Article
  6. Article
  7. Delayed progression of prion disease in mice by polyarginine-facilitated prevention of PrPNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Frontiers in cellular and infection microbiology · 2023
    Article
  18. Article
  19. Article
  20. The Cross-Species Immunity During AcuteFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Vitomir DjokicDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, United States.
Lavoisier AkooloDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, United States.
Nikhat ParveenDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, United States.
Rutgers New Jersey Medical SchoolRutgers, The State University of New Jersey · US

Funding

Borrelia burgdorferi-glycosaminoglycan interactions and Lyme disease pathogenesisR01AI089921 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PARVEEN, NIKHAT · 2011 to 2015
$1.7M
NIAID NIH HHS R01 AI089921
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Babesia microtibabesiosisblood-borne pathogenimmunosuppressionprotozoan pathogenesistick-borne infection

Identifiers

PMID29445365
PMCPMC5797759
OpenAlexW2793018748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.